Division of HIV/AIDS Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, 1600 Clifton Road NE, MS E46, Atlanta, GA, 30329, USA.
Oak Ridge Institute for Science and Education, 130 Badger Rd, Oak Ridge, TN, 37830, USA.
J Urban Health. 2020 Oct;97(5):739-748. doi: 10.1007/s11524-020-00479-x. Epub 2020 Sep 11.
In 2016, more than 90% of HIV diagnoses among young men aged 13-19 years were attributed to male-male sexual contact. Little is known about how binge drinking and non-injection drug use may be associated with risky sexual behavior among adolescent sexual minority males (ASMM). Using data from the National HIV Behavioral Surveillance, we examined how binge drinking and non-injection drug use may be associated with sexual risk among ASMM. ASMM were recruited for interviews in 3 cities: Chicago, New York City, and Philadelphia. Among 16-18-year-olds (N = 488), we evaluated the association between binge drinking (≥ 5 drinks in one sitting in the past 30 days), non-injection drug use (past 12-month use of methamphetamines, powder cocaine, downers, painkillers, ecstasy, poppers, and "other"), and two past 12-month sexual risk outcomes: condomless anal intercourse with a casual partner and having multiple sex partners. We used log-linked Poisson regression models with robust standard errors to estimate prevalence ratios (PR) and 95% confidence intervals (CI). Overall, 26% of 16-18-year-old ASMM binge drank, and 21% reported non-injection drug use. Among ASMM who binge drank, 34% reported condomless anal intercourse with a casual partner compared with 22% of those who did not (PR: 1.53, 95% CI: 1.04-2.26). Similarly, 84% of ASMM who binge drank reported having multiple partners compared with 61% of those who did not (PR: 1.38, 95% CI: 1.09-1.76). Among ASMM who used non-injection drugs, 37% reported condomless anal intercourse compared with 22% of those who did not (PR: 1.70, 95% CI 1.09-2.50), while 86% of those who used non-injection drugs had multiple partners compared with 62% of those who did not (PR: 1.40, 95% CI: 1.06-1.80). Our findings suggest that the prevalence of substance misuse is high among sexual minority youth and is associated with sexual risk in this population. Our findings highlight the need for high-quality HIV prevention programs for ASMM especially as HIV prevention programs for this population are scarce.
2016 年，13-19 岁青年男性中超过 90%的艾滋病诊断归因于男男性接触。对于狂欢饮酒和非注射吸毒如何与青少年性少数群体男性（ASMM）的危险性行为相关，人们知之甚少。利用全国艾滋病毒行为监测的数据，我们研究了狂欢饮酒和非注射吸毒如何与 ASMM 的性风险相关。ASMM 在 3 个城市（芝加哥、纽约市和费城）接受采访招募。在 16-18 岁（N=488）人群中，我们评估了狂欢饮酒（过去 30 天内一次性饮用 5 杯或以上）、非注射吸毒（过去 12 个月使用冰毒、可卡因粉末、镇静剂、止痛药、摇头丸、啪啪圈和“其他”）与过去 12 个月的两种性风险结果之间的关联：与偶然伴侣发生无保护的肛交和拥有多个性伴侣。我们使用对数链接泊松回归模型和稳健标准误差来估计患病率比（PR）和 95%置信区间（CI）。总体而言，26%的 16-18 岁 ASMM 狂欢饮酒，21%报告非注射吸毒。在狂欢饮酒的 ASMM 中，34%报告与偶然伴侣发生无保护的肛交，而不饮酒的比例为 22%（PR：1.53，95%CI：1.04-2.26）。同样，84%狂欢饮酒的 ASMM 报告拥有多个伴侣，而不饮酒的比例为 61%（PR：1.38，95%CI：1.09-1.76）。在非注射吸毒的 ASMM 中，37%报告与偶然伴侣发生无保护的肛交，而不吸毒的比例为 22%（PR：1.70，95%CI：1.09-2.50），而 86%非注射吸毒的 ASMM 拥有多个伴侣，而不吸毒的比例为 62%（PR：1.40，95%CI：1.06-1.80）。我们的研究结果表明，性少数青年群体中物质滥用的患病率很高，并且与该人群中的性风险相关。我们的研究结果强调了需要为 ASMM 提供高质量的艾滋病毒预防计划，特别是因为针对该人群的艾滋病毒预防计划很少。
